Core Viewpoint - A case in the A-share market highlights the integration of health benefits into shareholder rewards, showcasing the effectiveness of the company's technology in a real-life scenario [1] Group 1: Company Initiatives - BGI Genomics (华大基因) launched a shareholder reward program in February 2025, allowing shareholders who have held shares for over a year to receive a free health screening kit [1] - The company emphasizes the importance of health as part of its shareholder return system, enabling shareholders to experience the benefits of its technology firsthand [1] Group 2: Case Study - A 35-year-old shareholder participated in the annual shareholder reward activity and received a health screening, which led to the early detection of a tumor through a colonoscopy [1] - The shareholder had purchased BGI Genomics stock in July 2022 and underwent surgery in early July 2023, with a good recovery reported [1]